..Information to Pharmacists
    _______________________________

    Your Monthly E-Magazine
    DECEMBER, 2002

    Published by Computachem Services

    P.O Box 297.
    Alstonville. 2477
    NSW Australia

    Phone:
    61 2 66285138

    E-Mail
    This
    Page
    Click For a
    Printer-Friendly
    Page
    Bookmark
    This Page

    KARALYN HUXHAGEN

    PSA Councilor Perspective

    Second National Report on Patient Safety: Improving Medication Safety

    The document ‘Second National Report on Patient Safety: Improving Medication Safety’ produced by the Australian Council for Safety and Quality in Health Care is a wake up call for us all. Many people have commented that this paper only applies to hospital Pharmacy. This is not so.

    Some sobering thoughts from the report that I found significant:

    * ‘In any two-week period, around seven in ten Australians (and nine in ten older Australians) will have taken at least one medicine.’

    * ‘Every year there are over 100 million general practice encounters in Australia, with around 400,000 of these thought to involve adverse drug events’.

    * ‘Results suggest that between 2-3 percent of all hospital admissions may be medication related.’

    The report also stated:

    ‘In general practice, the most common medication incidents are the use of inappropriate medicine or dose and errors in administering or prescribing medications.
    Many of these are thought to be preventable. The most common types of dispensing errors involve selection of the incorrect strength of a medicine or selection of the incorrect product, which can occur when different products have similar packaging or names that sound alike.’

    One of my primary roles as a community pharmacist is to try and ensure that I am part of a ‘seamless pathway’ for my customers/patients health needs.
    I am appalled at some of the areas addressed in this document-there has been much discussion on the poor transition of care that occurs when a patient is discharged from hospital to the community but what about the other way around?
    If you are providing a medication assistance service for this patient in the form of managed dose packs eg Webster’s, Persocare and the patient is admitted to hospital, do you provide a copy of your latest medication profile and history notes to the admitting Doctor (with the patients’ permission of course)? With the advent of rostered after hours services and large practices the admitting Doctor is not always the patients regular Doctor.
    Why should it just be a one-way communication process?

    Pharmacists bleat long and hard about wanting to be a professional member of the health care team but you must put in the hard work to be seen and heard as having a role.
    How much easier have DMMR’s been to deliver than the original RMMR’s were.
    We learnt by our mistakes, had a better model in place and knew what pitfalls not to fall into-it took hard work, blood, sweat and tears but I know I receive far better communication from the Drs with a DMMR than I ever did with the RMMR’s that were thrust upon the Drs by us belligerent Pharmacists.
    This report highlights that community based medication management services and case conferencing have been a key strategy in helping to reduce medication incidents.

    Another area that this report highlights is the large degree of under reporting to ADRAC by health professionals.
    This is of particular concern as many of the newer drugs have not had long term clinical testing and some of the problems may not appear till well down the track.
    The report highlights the fact that it is estimated that 50% of marketed medicines have serious adverse drug reactions first detected after marketing.
    ADRAC reporting is particularly important for OTC and complementary medications, as we do not have very much data on a lot of these products.
    It is particularly pleasing that Emims now lists the ADRAC reports in the drug profile so you can see what has been reported.

    Simple techniques that make up best practice dispensing guidelines form a large part of this report.
    For example, check the prescription to the drug three times in three different ways, attach the repeat forms to the duplicates, ensure notations of dispensing date and pharmacy are on the duplicate, cancel items on the duplicates, keep the dispensary layout neat and tidy with a clear definition between alike products.

    Another area highlighted in the report is that Pharmacists appear to be unaware of the Interpreter services that are available through community health centres.
    In my area we use these services for all health professionals having to interact with non-English speaking patients, but for some reason Pharmacists are often left out of this loop.

    The use of barcode scanners in pharmacy practice is one area highlighted in the report as needing to be advanced by software suppliers.
    The current system of only checking at the end will not eliminate all errors and a more through process needs to be in place.
    The problem with this is that we still do not have uniform bar coding on all of our products but this is being addressed.
    The other problem is that the BMMS and Healthconnect projects have not been progressed as quickly as many of us would have liked.
    The report does highlight the fact that there is no evidence in the Australian or international literature to support the theory that current automated dispensing devices reduce medication errors or improve patient outcomes

    The use of CMI’s and the ‘correct’ way to deliver this information has been the subject of a project commissioned by PSA at a National level.
    PSA has now produced an educational tool to help Pharmacists understand the communication strategies needed to be implemented to deliver CMI’s effectively and efficiently.
    These communication strategies are similar to the communication strategies that we all learnt within the better counselling skills of the Pharmacy only and Pharmacist only project.
    CMI’s are an important tool when avoiding medication misadventures.

    I recently had a patient started on ‘Akineton’ by his regular GP that he has been seeing for at least 20 years.
    He came back to see me the next day with his CMI in hand quite distraught.
    Had I forgotten that he had glaucoma?
    In this document he was brandishing it told him not to use Akineton if he had glaucoma.
    How could I not have picked this up!!

    This report is well worth a read as it is a wake up call to all of who try to be too many people in one day in our busy community Pharmacies.
    We are a competent health professional and we should plan our day to act like one.

    A Happy Christmas to all, and medicine-safe New Year wishes.
    From
    Karalyn Huxhagen

     


    Back to Front Page